| Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy |
41 |
| E-cigarettes: Impact of E-liquid Components and Device Characteristics on Nicotine Exposure |
36 |
| Imaging the Role of Inflammation in Mood and Anxiety-related Disorders |
32 |
| Cannabidiol Adverse Effects and Toxicity |
31 |
| Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain |
28 |
| Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors |
25 |
| Recent Advances in Pathophysiology of Traumatic Brain Injury |
23 |
| Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging |
21 |
| Therapeutic Strategies for Treatment of Inflammation-related Depression |
20 |
| Impact of Dietary Fats on Brain Functions |
19 |
| The Challenge of microRNA as a Biomarker of Epilepsy |
18 |
| The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Patho-physiological Mechanisms and Novel Treatments |
18 |
| Cognitive Effects of Nicotine: Recent Progress |
17 |
| Levodopa in Parkinson's Disease: Current Status and Future Developments |
17 |
| Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness |
17 |
| Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options |
17 |
| Review: 5-HT 5-HT 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System |
17 |
| Nerve Growth Factor: Early Studies and Recent Clinical Trials |
16 |
| Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences |
16 |
| Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders |
16 |
| New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on alpha 7 nAChRs |
15 |
| TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endo-cannabinoids and Nociceptive Signalling |
15 |
| Neuroprotective Strategies for Neurological Disorders by Natural Products: An update |
14 |
| NGF and BDNF Alterations by Prenatal Alcohol Exposure |
14 |
| Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases |
13 |
| Strategies to Reduce Oxidative Stress in Glaucoma Patients |
13 |
| Is the Impact of Starvation on the Gut Microbiota Specific or Unspecific to Anorexia Nervosa? A Narrative Review Based on a Systematic Literature Search |
12 |
| Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms |
12 |
| Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges |
12 |
| Programmed Cell Death after Intracerebral Hemorrhage |
12 |
| y Systematic Review of Food Addiction as Measured with the Yale Food Addiction Scale: Implications for the Food Addiction Construct |
12 |
| Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis |
11 |
| Does Ceruloplasmin Defend Against Neurodegenerative Diseases? |
11 |
| Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design |
11 |
| Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis |
11 |
| The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases |
11 |
| Premorbid and Illness-related Social Difficulties in Eating Disorders: An Overview of the Literature and Treatment Developments |
10 |
| Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population |
10 |
| Drug-Resistant Epilepsy and Surgery |
10 |
| Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects |
10 |
| Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update |
10 |
| Suicide Risk in Obsessive-Compulsive Disorder and Exploration of Risk Factors: A Systematic Review |
10 |
| P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke |
9 |
| Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder |
9 |
| NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review |
9 |
| Synaptic Elimination in Neurological Disorders |
9 |
| School-based Prevention for Adolescent Internet Addiction: Prevention is the Key. A Systematic Literature Review |
9 |
| Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde? |
9 |
| Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD) |
9 |
| Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease |
9 |
